Regulus Therapeutics

RGLS

NASDAQHealth Care

Income Statement

Total Revenue$0

Gross Profit$0

Operating Income$-50.04M

EBITDA$-45.85M

EBIT$-46.2M

Pre-tax Income$-47.52M

Net Income$-46.36M

Cash Equivalent$27.96M

Total Debt$708.25K

Book Value$92.25M

Book Value Per Share1.41

Return on Equity (ROE)-60.67%

Return on Assets (ROA)-55.07%

Return on Invested Capital (ROI)-60.67%

Net Profit Margin-157.21%

Current Ratio10.98

Quick Ratio10.11

Long-Term Debt / Equity0.00